Invention Grant
- Patent Title: Polymorphs and salts of a kinase inhibitor
- Patent Title (中): 激酶抑制剂的多晶型物和盐
-
Application No.: US12952879Application Date: 2010-11-23
-
Publication No.: US08853235B2Publication Date: 2014-10-07
- Inventor: David M. Ryckman , Michael Schwaebe
- Applicant: David M. Ryckman , Michael Schwaebe
- Applicant Address: TW New Taipei
- Assignee: Senhwa Biosciences, Inc.
- Current Assignee: Senhwa Biosciences, Inc.
- Current Assignee Address: TW New Taipei
- Agency: Cooley LLP
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; C07D471/04 ; A61K31/54
Abstract:
The present invention relates to novel crystalline polymorphic salt forms of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid, processes for the preparation thereof, compositions thereof and their use in methods of treatment and prevention of conditions mediated by casein kinase (CK) and/or poly(ADP-ribose)polymerase (PARP).
Public/Granted literature
- US20110160240A1 POLYMORPHS AND SALTS OF A KINASE INHIBITOR Public/Granted day:2011-06-30
Information query
IPC分类:
